Cover
Cover | Mar. 11, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 3, 2021 |
Entity File Number | 001-37809 |
Entity Registrant Name | NeuroBo Pharmaceuticals, Inc. |
Entity Central Index Key | 0001638287 |
Entity Tax Identification Number | 47-2389984 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 200 Berkeley Street |
Entity Address, Address Line Two | 19th Floor |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02116 |
City Area Code | 857 |
Local Phone Number | 702-9600 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | NRBO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |